STOCK TITAN

Insider of ALNY plans Nasdaq sale of 2,041 shares after prior disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of ALNY has filed a notice to sell 2,041 common shares through UBS Financial Services on or about February 17, 2026 on Nasdaq, with an indicated aggregate market value of $677,531.58. The filing shows these shares were acquired on February 12, 2026 via a PSU (performance stock unit) transaction with the issuer.

The insider previously sold 12,128 common shares on November 17, 2025 for $5,483,998.14 and 2,290 common shares on January 13, 2026 for $848,062.57. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or future operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for ALNY disclose about upcoming share sales?

The filing discloses an insider’s intent to sell 2,041 common shares of ALNY on or about February 17, 2026 on Nasdaq, with an estimated aggregate market value of $677,531.58 based on the figures reported in the notice.

How many ALNY shares has the insider sold in the past three months?

The insider sold 12,128 common shares on November 17, 2025 and 2,290 common shares on January 13, 2026. Reported gross proceeds were $5,483,998.14 and $848,062.57, respectively, according to the Form 144 disclosure.

What is the total ALNY share count referenced in this Form 144 filing?

The notice states that 132,623,144 common shares are outstanding. This figure provides context for the planned sale of 2,041 shares, indicating the sale represents a very small portion of the issuer’s total common stock base.

How were the ALNY shares to be sold under this Form 144 acquired?

The 2,041 common shares to be sold were acquired on February 12, 2026 through a PSU (performance stock unit) transaction from the issuer. The filing also lists February 12, 2026 as the date of payment for these acquired securities.

Which broker is handling the planned ALNY share sale under this Form 144?

The planned sale of 2,041 ALNY common shares is to be handled by UBS Financial Services, Inc., located at 11 Madison Avenue, 4th Floor, New York, NY 10010, with the shares expected to be sold on the Nasdaq exchange.

What representation does the ALNY insider make about undisclosed information in the Form 144?

The insider represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, which is a standard certification included in the Form 144 notice language.
Alnylam Pharmaceuticals Inc

NASDAQ:ALNY

ALNY Rankings

ALNY Latest News

ALNY Latest SEC Filings

ALNY Stock Data

44.12B
131.24M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE